Milestone’s shares dive after FDA again rejects drug for abnormal heart rhythmnews2025-03-28T14:51:44+00:00March 28th, 2025|Endpoints News|
European regulator rejects Lilly’s Alzheimer’s drug over side effectsnews2025-03-28T13:48:24+00:00March 28th, 2025|Endpoints News|
Novo makes oral obesity drug partnership with Lexicon worth up to $1Bnews2025-03-28T11:30:08+00:00March 28th, 2025|Endpoints News|
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025news2025-03-27T17:51:01+00:00March 27th, 2025|Endpoints News|
New pharma tariffs could put generic drugmakers under pressurenews2025-03-27T17:10:05+00:00March 27th, 2025|Endpoints News|
HHS plans to cut 10,000 more staffers in major downsizingnews2025-03-27T13:20:47+00:00March 27th, 2025|Endpoints News|
Exelixis’ cancer drug wins approval for neuroendocrine tumorsnews2025-03-26T18:29:44+00:00March 26th, 2025|Endpoints News|
Why did radiopharma biotech Actinium hold an investor event at Mar-a-Lago?news2025-03-26T17:05:53+00:00March 26th, 2025|Endpoints News|
J&J touts new survival data for lung cancer combonews2025-03-26T16:01:33+00:00March 26th, 2025|Endpoints News|
Trump tariffs would increase biopharma costs — industry surveynews2025-03-26T10:00:16+00:00March 26th, 2025|Endpoints News|
